跳至主要内容
临床试验/NCT05961826
NCT05961826进行中(未招募)不适用

National Cohort About Epidemiology, Clinical and Genetic Heterogeneity of the "Low-Phospholipid-Associated Cholelithiasis" (LPAC) Syndrome

Institut National de la Santé Et de la Recherche Médicale, France21 个研究点 分布在 1 个国家目标入组 650 人开始时间: 2017年11月6日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
650
试验地点
21
主要终点
Descriptive analysis of the clinical manifestations of LPAC syndrome like personal and family medical history of the disease, clinical features, medical complications, co-morbidities, death (age of onset and cause).

研究概览

简要总结

The goal of this observational study is to describe the various clinical, biological and radiological manifestations of LPAC syndrome, defined according to standard diagnostic criteria, or according to criteria extended to all symptomatic recurrent biliary lithiasis, and delineate the various possible evolutions.

Participants will be followed for 5 years and the inclusion sites will collect the necessary data at least once a year as part of routine patient care. A quality of life self-questionnaire will be completed by participants during these visits.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
13 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Children or adults meeting the standard* or extended** diagnostic criteria for LPAC syndrome:
  • First symptoms before the age of 40 years
  • Radiological images compatible with the existence of intrahepatic lithiasis
  • Recurrence of symptoms after cholecystectomy
  • (*) standard criteria: symptomatic biliary lithiasis with at least 2 out of 3 criteria
  • (**) extended criteria: symptomatic biliary lithiasis with 1 out of 3 criteria

排除标准

  • Patients who have undergone liver transplantation

结局指标

主要结局

Descriptive analysis of the clinical manifestations of LPAC syndrome like personal and family medical history of the disease, clinical features, medical complications, co-morbidities, death (age of onset and cause).

时间窗: Through study completion, an average of 5 years

Descriptive analysis of the biological manifestations of LPAC syndrome like hepatic biochemical tests and glucido-lipid tests

时间窗: Through study completion, an average of 5 years

Descriptive analysis of the radiological manifestations of LPAC syndrome like presence of stones or signs of intrahepatic, vesicular or main bile duct micro-lithiasis

时间窗: Through study completion, an average of 5 years

次要结局

  • Description of patient management practices.(Through study completion, an average of 5 years)
  • Assessing the impact of LPAC syndrome on quality of life.(Through study completion, an average of 5 years)
  • Description of diagnostic practices by a descriptive analysis of sequences of medical procedures used to diagnose LPAC syndrome.(Through study completion, an average of 5 years)
  • Description of therapeutic practices by a descriptive analysis of the different curative and symptomatic treatments offered depending on the stage of the disease and the type of extra-hepatic complications.(Through study completion, an average of 5 years)
  • Identification of prognostic factors (clinical, biochemical, radiological) associated with a poor therapeutic response by assessing the occurrence of events such as : - Fatal or non-fatal complications - Death due to hepatic or other causes(Through study completion, an average of 5 years)
  • Evaluation of response to medical and interventional treatments.(Through study completion, an average of 5 years)
  • Identification of new diagnostics by refining the collection of semiological fields of 1st degree relatives and including patients with recurrent symptomatic biliary lithiasis who do not fully meet the current diagnostic criteria for LPAC syndrome(Through study completion, an average of 5 years)
  • Evaluation of the proportion of patients referred to LPAC within the population referred to the hepatology and/or digestive surgery departments for biliary lithiasis during the same study period(Through study completion, an average of 5 years)

研究者

发起方
Institut National de la Santé Et de la Recherche Médicale, France
申办方类型
Other Gov
责任方
Sponsor

研究点 (21)

Loading locations...

相似试验